Fig. 1From: Hepatitis B virus reactivation in cancer patients with positive Hepatitis B surface antigen undergoing PD-1 inhibitionFlow chart depicting patient deposition. PD-1, programmed cell death 1; PD-L1, programmed cell death-ligand 1; HBsAg, hepatitis B surface antigen; HBV, hepatitis B virus; anti-HCV, antibody to the hepatitis C virus; HBcAb, hepatitis B core antibodyBack to article page